Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Shoals Technologies Group, Inc. - SHLS


NEW YORK, April 12, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shoals Technologies Group, Inc. ("Shoals" or the "Company") (NASDAQ: SHLS).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Shoals and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until May 21, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Shoals securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.     

[Click here for information about joining the class action]  

On November 7, 2023, Shoals filed its Quarterly Report on Form 10-Q for the third quarter of 2023 with the United States Securities and Exchange Commission and held an accompanying earnings call in which it was revealed that an issue involving excessive pull back of wire insulation, or "shrinkback," was far more severe than previously disclosed.  Specifically, the Company reported that the shrinkback issue affected 30% of Shoals' harnesses installed between 2020 and 2022, booked a $50.2 million warranty expense for the quarter related to the shrinkback issue, and provided a range of potential loss related to the shrinkback issue of $59.7 million to $184.9 million

On this news, Shoals' stock price fell $3.28 per share over the next two trading days, or 20.2%, to close at $12.95 per share on November 9, 2023.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.   

Attorney advertising.  Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 10:00
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week. "With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...

at 09:00
On Wednesday, Inman, the real estate industry's leading source of journalism, proudly announced the honorees of its 2024 Future Leaders in Real...

at 08:32
QNB Group, the largest financial institution in the Middle East and Africa, is proud to announce the signing of renowned actor Ahmed Helmy as its new brand ambassador. The announcement comes in line with the Group's vision and the values of...

at 08:05
(BRK.A; BRK.B) ? Berkshire's operating results for the first quarters of 2024 and 2023 are summarized in the following paragraphs. However, we urge investors and reporters to read our 10-Q, which has been posted at www.berkshirehathaway.com. The...

at 08:00
Settlements have been reached with Deutsche Bank, TD, Nomura, Credit Suisse, RBC, Barclays, BNP, Citigroup, and Credit Agricole (the "Settling Defendants") in a proposed class action relating to supranational, sovereign, sub-sovereign, governmental,...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...



News published on and distributed by: